Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmelo Anile

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Frontiers in Endocrinology|July 29, 2021
Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot StudyChiara Bima, Sabrina Chiloiro, Antonella Giampietro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Stem cell marker nestin and c-Jun NH2-terminal kinases in tumor and peritumor areas of glioblastoma multiforme: possible prognostic implicationsAnnunziato Mangiola, Gina Lama, Cecilia Giannitelli, et al.
International Journal of Oncology|May 10, 2007
Activated ERK1/2 expression in glioblastoma multiforme and in peritumor tissueGina Lama, Annunziato Mangiola, Carmelo Anile, et al.
The Journal of Clinical Endocrinology and Metabolism|June 21, 2019
Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second-Line Therapies: A Longitudinal StudySabrina Chiloiro, Chiara Bima, Tommaso Tartaglione, et al.
Neurosurgery|September 9, 2011
Postoperative infection may influence survival in patients with glioblastoma: simply a myth?Pasquale De Bonis, Alessio Albanese, Giorgio Lofrese, et al.
Neuroendocrinology|January 31, 2015
Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosisSabrina Chiloiro, Francesco Doglietto, Barbara Trapasso, et al.
Pituitary|December 31, 2011
Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case-control studyAlessandra Fusco, Antonella Giampietro, Antonio Bianchi, et al.
Anticancer Research|May 13, 2015
Radiosurgery or Fractionated Stereotactic Radiotherapy plus Whole-brain Radioherapy in Brain Oligometastases: A Long-term AnalysisMario Balducci, Rosa Autorino, Silvia Chiesa, et al.
Plos One|March 9, 2013
Gene expression profile of glioblastoma peritumoral tissue: an ex vivo studyAnnunziato Mangiola, Nathalie Saulnier, Pasquale De Bonis, et al.
Journal of Neuro-Oncology|August 26, 2009
Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II studyMario Balducci, Giuseppe Roberto D'Agostino, Stefania Manfrida, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Frontiers in Endocrinology|July 29, 2021
Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot StudyChiara Bima, Sabrina Chiloiro, Antonella Giampietro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Stem cell marker nestin and c-Jun NH2-terminal kinases in tumor and peritumor areas of glioblastoma multiforme: possible prognostic implicationsAnnunziato Mangiola, Gina Lama, Cecilia Giannitelli, et al.
International Journal of Oncology|May 10, 2007
Activated ERK1/2 expression in glioblastoma multiforme and in peritumor tissueGina Lama, Annunziato Mangiola, Carmelo Anile, et al.
The Journal of Clinical Endocrinology and Metabolism|June 21, 2019
Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second-Line Therapies: A Longitudinal StudySabrina Chiloiro, Chiara Bima, Tommaso Tartaglione, et al.
Neurosurgery|September 9, 2011
Postoperative infection may influence survival in patients with glioblastoma: simply a myth?Pasquale De Bonis, Alessio Albanese, Giorgio Lofrese, et al.
Neuroendocrinology|January 31, 2015
Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosisSabrina Chiloiro, Francesco Doglietto, Barbara Trapasso, et al.
Pituitary|December 31, 2011
Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case-control studyAlessandra Fusco, Antonella Giampietro, Antonio Bianchi, et al.
Anticancer Research|May 13, 2015
Radiosurgery or Fractionated Stereotactic Radiotherapy plus Whole-brain Radioherapy in Brain Oligometastases: A Long-term AnalysisMario Balducci, Rosa Autorino, Silvia Chiesa, et al.
Plos One|March 9, 2013
Gene expression profile of glioblastoma peritumoral tissue: an ex vivo studyAnnunziato Mangiola, Nathalie Saulnier, Pasquale De Bonis, et al.
Journal of Neuro-Oncology|August 26, 2009
Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II studyMario Balducci, Giuseppe Roberto D'Agostino, Stefania Manfrida, et al.
Pageof 10